Goal #4

Medicines, Technologies, and Innovation
In Alignment with Ghana’s National Strategy for Sickle Cell Disease
Strategic objective 4: Improve health outcomes of individuals with SCD
Implementation Strategy 3: Improve Facilities, Laboratory, and Diagnostic Capacities, Equipment, Infrastructure
Our Goal for Previous Hydroxyurea Availability

Adjusting for inflation, to assist in restoring the availability and affordability of hydroxyurea to 2022 levels of program activity

Our Goal for the Previous Hydroxyurea Ahodwo Program

To assist in restoring the national Ahodwo program for the distribution, monitoring, and management of hydroxyurea

Our Goal for Future Hydroxyurea Availability

To assist in identifying, and beginning to implement, a plan for the timely scaling up of the availability and affordability of hydroxyurea.

Our Goal for Stroke Prevention and TCD

To assist in identifying, and beginning to implement, a plan for the timely scaling up of transcranial doppler (TCD) screening for stroke prevention

Our Goal for SPARCo Standards of Care

To assist in supporting the implementation of the SPARCo Standards of Care for Sickle Cell Disease in Sub-Saharan Africa that address:

• Diagnosis
• Health Maintenance and Preventive Therapy
• Screening for Specific Conditions
• Special Management Protocols

The SPARCo Standards of Care

The SPARCo Standards of Care